InsidersTradesSigma
Total declarations
Company
▲ Purchases (13 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
13
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Samsara BioCapital, L.P.. Insider active across 1 company, notably Graphite Bio, Inc.. Aggregated, 15 disclosures have been recorded. Breakdown: 13 buys · 0 sell. Total volume traded: €9.3m. History available since 6 October 2021. The latest transaction was filed on 11 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations15 total
74,464 shares@ US$4.073.0% of flowCommon StockSEC:0001209191-22-024364:0
Ideal exit: 6 Jan 2023 (T+270)
100,000 shares@ US$8.998.5% of flowCommon StockSEC:0001209191-22-004735:0
Ideal exit: 18 Oct 2022 (T+270)
100,000 shares@ US$8.998.5% of flowCommon StockSEC:0001209191-22-004735
Ideal exit: 18 Oct 2022 (T+270)
54,565 shares@ US$9.244.8% of flowCommon StockSEC:0001209191-22-004346
Ideal exit: 16 Oct 2022 (T+270)
54,565 shares@ US$9.244.8% of flowCommon StockSEC:0001209191-22-004346:0
Ideal exit: 16 Oct 2022 (T+270)
22,329 shares@ US$10.192.2% of flowCommon StockSEC:0001209191-21-070500
Ideal exit: 11 Sept 2022 (T+270)
22,329 shares@ US$10.192.2% of flowCommon StockSEC:0001209191-21-070500:0
Ideal exit: 11 Sept 2022 (T+270)
201,685 shares@ US$10.1519.5% of flowCommon StockSEC:0001209191-21-066742
Ideal exit: 19 Aug 2022 (T+270)
201,685 shares@ US$10.1519.5% of flowCommon StockSEC:0001209191-21-066742:0
Ideal exit: 19 Aug 2022 (T+270)
45,400 shares@ US$13.225.6% of flowCommon StockSEC:0001209191-21-060627:0
Ideal exit: 10 Jul 2022 (T+270)
45,400 shares@ US$13.225.6% of flowCommon StockSEC:0001209191-21-060627
Ideal exit: 10 Jul 2022 (T+270)
61,475 shares@ US$13.837.9% of flowCommon StockSEC:0001209191-21-060060:0
Ideal exit: 3 Jul 2022 (T+270)
61,475 shares@ US$13.837.9% of flowCommon StockSEC:0001209191-21-060060
Ideal exit: 3 Jul 2022 (T+270)
6,167,763 sharesCommon StockSEC:0001209191-21-044507:0
6,167,763 sharesCommon StockSEC:0001209191-21-044507
15 of 15 declarations
About Samsara BioCapital, L.P.
Samsara BioCapital, L.P. is an investor in Graphite Bio, Inc. and plays a key role in the company's funding.
